US 11858941
Heterocyclic and heteroaryl compounds for treating Huntington's disease
granted A61PA61P25/00A61P25/14
Quick answer
US patent 11858941 (Heterocyclic and heteroaryl compounds for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/28